FDA allows Amarin to market off-label use of Vascepa

Stephen Feller
BETHESDA, Md., March 9 (UPI) -- The FDA agreed to allow pharmaceutical company Amarin to promote off-label uses for its drug Vascepa not approved by the agency, according to the company.